LFWD
Lifeward Ltd.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 18 Lifeward reported declining revenue and earnings for Q4 and full-yea…
- Mar 25 ▲ Lifeward Ltd. has closed a strategic partnership with Oramed Pharmac…
- Apr 27 ▼ Lifeward Ltd. filed an S-3 registration statement on April 27, 2026,…
- May 13 ▼ The SEC declared effective Lifeward's Form S-3 registration statemen…
- May 15 ▼ Lifeward reported Q1 2026 revenue of $3.9M (down 22% YoY) and a GAAP…
- May 15 ▼ Lifeward reported Q1 2026 revenue of $3.9M, down 22% YoY from $5.0M,…
- Aug 11 ▼ Lifeward Ltd.'s S-3 shelf registration (File No. 333-297919) became…
- Aug 14 Lifeward reported Q2 2026 revenue of $6.6M (+16% YoY), its strongest…
- Aug 14 ▼ Lifeward reported Q2 2026 revenue of $6.6M (+16% YoY), slightly abov…
- Sep 25 ▼ Lifeward's 2026 proxy statement reveals a company in transition foll…
- Oct 1 Trading halt: Halt Resumed: LFWD, trading resumed after LUDP (Volatility…
- Nov 13 ▼ Lifeward reported Q3 2026 revenue of $5.4M, down 12% YoY from $6.2M,…
- Nov 13 New catalyst: subscribers see the details Unlock
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q3 2026: 1 added (0 new), 0 trimmed or exited.
- AnalystsBULLISH
7 of 8 rate it Buy or better.
- Short sellersSTEADY
Short interest −2.6% to 87.3K shares. 5.0 days to cover, ≈3.1% of shares.
- TrendDOWNTREND
42% below its 50-day average. New closing low $3.62 on Nov 16.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| OSAIC HOLDINGS, INC. | DOUBLED | $1.5K |
| MORGAN STANLEY | ADD | $2.1K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
8 analysts| Date | Firm | Rating |
|---|---|---|
| Nov 16, 2026 | 🔒 Fresh data, subscribers only MAINTAIN |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Gabay Avraham Director Aug 20, 2026 | AWARD | 13,643 sh |
Zamir Haggai Director Aug 14, 2026 | AWARD | 6,711 sh |
Greenwald Yonason Director Aug 14, 2026 | AWARD | 6,711 sh |
Rose Keith Dale Chief Medical Officer May 1, 2026 | AWARD | 15,000 sh |
Kidron Miriam Director Mar 25, 2026 | AWARD | 7,657 sh |
KIDRON NADAV Director Mar 25, 2026 | AWARD | 7,657 sh |
Sigsbee William Mark Director Mar 25, 2026 | AWARD | 11,485 sh |
Rozenbaum Moshe H Director Mar 25, 2026 | AWARD | 11,485 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026| Oct 1, 2026 | Volatility Pause | Resumed |
Washington
SecBot reports
21 filings · 4 press releases · 0 bullish · 9 bearish · 1 mixed · 11 neutral- BEARISH PRESS-RELEASENov 13, 2026
Lifeward reported Q3 2026 revenue of $5.4M, down 12% YoY from $6.2M, missing the $7.2M consensus…
Monitor the ReWalk channel-partner transition for signs of revenue stabilization in Q4; the company's cash runway at current burn rate appears tight, raising the risk of a dilutive capital raise.
- NEUTRAL 3Nov 12, 2026
Ariel Kallner filed a Form 3 initial statement of beneficial ownership with Lifeward Ltd…
Routine insider onboarding filing with no market signal. Monitor future Form 4 filings for any subsequent open-market purchases or grants that could indicate insider conviction.
- NEUTRAL 3Nov 3, 2026
Ronen Tsimerman filed a Form 3 initial statement of beneficial ownership upon becoming Chief…
This is a routine initial ownership filing for a new CFO. No immediate trading signal; monitor future Form 4 filings for insider buying or selling activity.
- NEUTRAL 8-KOct 27, 2026
Lifeward Ltd. appointed Ronen Tsimerman as Chief Financial Officer, effective November 1, 2026…
Monitor the October 30 annual general meeting for shareholder approval of the renewed compensation policy, which is a condition precedent to the CFO employment agreement. The appointment itself is…
All LFWD filing & press-release reports (25)
- PRESS-RELEASE reportNov 13, 2026
- 3 reportNov 12, 2026
- 3 reportNov 3, 2026
- 8-K reportOct 27, 2026
- 8-K reportOct 8, 2026
- 8-K reportOct 1, 2026
- DEF 14A reportSep 25, 2026
- 8-K reportAug 14, 2026
- PRESS-RELEASE reportAug 14, 2026
- EFFECT reportAug 11, 2026
- PRESS-RELEASE reportAug 7, 2026
- 8-K reportMay 19, 2026
- PRESS-RELEASE reportMay 15, 2026
- 8-K reportMay 15, 2026
- EFFECT reportMay 13, 2026
- PRESS-RELEASE reportMay 11, 2026
- S-3 reportApr 27, 2026
- 3 reportMar 27, 2026
- 3 reportMar 27, 2026
- PRESS-RELEASE reportMar 25, 2026
- 8-K reportMar 18, 2026
- PRESS-RELEASE reportMar 18, 2026
- PRESS-RELEASE reportMar 13, 2026
- PRESS-RELEASE reportMar 10, 2026
- 8-K reportFeb 25, 2026